France's drug industry group (LEEM) has called for a solution to the problem of donating unused drugs to developing countries. Earlier this year, the French health authorities issued a ban on the reuse for humanitarian purposes of medicines.
In the meantime, the LEEM and its emergency relief partner Tulipe have been scaling back on the list of products that they are able to supply to non-governmental organizations in poorer countries. Where possible, the drug firms are supplying new product and discussions are underway to determine how this scheme will be funded.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze